Novozymes reported 437.8M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Arq USD 21.68M 7.08M Mar/2026
Avient USD 574.8M 43.8M Mar/2026
Chemours USD 1.17B 5M Mar/2026
Coronado Global Resources USD 517.59M 12.28M Mar/2026
Corteva USD 2.91B 380M Jun/2026
Metallus USD 261.3M 9.6M Dec/2025
Newmont Corporation USD 2.57B 25M Mar/2026
Novozymes 437.8M 83.2M Dec/2025
SSR Mining USD 225.3M 34.8M Mar/2026